611
Views
37
CrossRef citations to date
0
Altmetric
Review

Executive dysfunction in major depressive disorder

Pages 79-83 | Published online: 10 Jan 2014

References Papers of special note have been highlighted as: • of interest •• of considerable interest

  • APA. Diagnostic and Statistical Manual of Mental Disorders IV. Fourth Edition. American Psychiatric Press, Washington DC, USA (1994).
  • Elliott R. Executive functions and their disorders. Br. Med. Bull.65, 49–59 (2003).
  • Ravnkilde B, Videbech P, Clemmensen K, Egander A, Rasmussen NA, Rosenberg R. Cognitive deficits in major depression. Scand. J. Psych.43(3), 239–251 (2002).
  • Moritz S, Birkner C, Kloss M et al. Impact of comorbid depressive symptoms on neuropsychological performance in obsessive–compulsive disorder. J. Ab. Psychology110(4), 653–657 (2001).
  • Trichard C, Martinot JL, Alagille M et al. Time course of prefrontal lobe dysfunction in severely depressed in-patients: a longitudinal neuropsychological study. Psychol. Med.25(1), 79–85 (1995).
  • Elliott R, Baker SC, Rogers RD et al. Prefrontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography. Psychol. Med.27(4), 931–942 (1997).
  • Purcell R, Maruff P, Kyrios M, Pantelis C. Neuropsychological function in young patients with unipolar major depression. Psychol. Med.27(6), 1277–1285 (1997).
  • Fossati P, Ergis AM, Allilaire JF. Executive functioning in unipolar depression: a review. Encephale28(2), 97–107 (2002).
  • Channon S, Green PS. Executive function in depression: the role of performance strategies in aiding depressed and non-depressed participants. J. Neurol. Neurosurg. Psych.66(2), 162–171 (1999).
  • Austin MP, Mitchell P, Wilhelm K et al. Cognitive function in depression: a distinct pattern of frontal impairment in melancholia? Psychol. Med.29(1), 73–85 (1999).
  • Degl’Innocenti A, Agren H, Backman L. Executive deficits in major depression. Acta Psych. Scand.97(3), 182–188 (1998).
  • Elliott R, McKenna PJ, Robbins TW, Sahakian BJ. Neuropsychological evidence for frontostriatal dysfunction in schizophrenia. Psych. Med.25(3), 619–630 (1995).
  • Merriam EP, Thase ME, Haas GL, Keshavan MS, Sweeney JA. Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance. Am. J. Psych.156(5), 780–782 (1999).
  • Henriques JDR. Decreased responsiveness to reward in depression. Cog. Emotion14(5), 711–742 (2000).
  • Kindermann SS, Kalayam B, Brown GG, Burdick KE, Alexopoulos GS. Executive functions and P300 latency in elderly depressed patients and control subjects. Am. J. Geriatric Psych.8(1), 57–65 (2000).
  • Schatzberg A, Khalezhan M, Rothschild AJ. Neuropsychologica deficits in psychotic versus nonpsychotic major depression and no mental illness. Am. J. Psychiatry157, 1095–1100 (2000).
  • Hill SK, Keshavan MS, Thase ME, Sweeney JA. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression. Am. J. Psych.161(6), 996–1003 (2003).
  • Schatzberg AF, Rothschild AJ. Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? Am. J. Psychiatry149(6), 733–745 (1992).
  • Tohen M, Stoll AL, Strakowski SM et al. The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome. Schiz. Bull.18(2), 273–282 (1992).
  • Kiosses DN, Alexopoulos GS, Murphy C. Symptoms of striatofrontal dysfunction contribute to disability in geriatric depression. Int. J. Geriatric Psych.15(11), 992–999 (2000).
  • Lockwood KA, Alexopoulos GS, van Gorp WG. Executive dysfunction in geriatric depression. Am. J. Psychiatry159(7), 1119–1126 (2003).
  • Alexopoulos GS, Meyers BS, Young RC et al. Executive dysfunction and long-term outcomes of geriatric depression. Arch. Gen. Psych.57(3), 285–290 (2000).
  • Dunkin JJ, Leuchter AF, Cook IA et al. Executive dysfunction predicts nonresponse to fluoxetine in major depression. J. Affect. Dis.60(1), 13–23 (2000).
  • Kalayam BAG. Prefrontal dsyfunction and treatment response in geriatric depression. Arch. Gen. Psych.56, 713–718 (1999).
  • Stahl S. Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. J. Clin. Psychiatry64(Suppl. 14), 6–17.
  • Batejat DM, Lagarde DP. Naps and modafinil as countermeasures for the effects of sleep deprivation on cognitive performance. Aviation Space Environmental Med.70(5), 493–498 (1999).
  • Turner DC, Clark L, Pomarol-Clotet E, McKenna P, Robbins TW, Sahakian BJ. Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology29(7), 1363–1373 (2004).
  • Rugino TA, Samsock TC. Modafinil in children with attention-deficit hyperactivity disorder. Pediatric Neurol.29(2), 136–142 (2003).
  • Taylor FB, Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J. Child Adolesc. Psychopharmacol.10(4), 311–320 (2000).
  • Schwartz JR, Nelson MT, Schwartz ER, Hughes RJ. Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness. Clin. Neuropharmacol.27(2), 74–79 (2004).
  • DeBattista C, Lembke A, Solvason HB, Ghebremichael R, Poirier J. A prospective trial of modafinil as an adjunctive treatment of major depression. J. Clin. Psychopharmacol.24(1), 87–90 (2004).
  • Magill R. Effects of tyrosine, phentermine, caffeine D-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation. Nut. Neurosci.6(4), 237–246 (2003).
  • Vance AL, Maruff P, Barnett R. Attention deficit hyperactivity disorder, combined type: better executive function performance with longer-term psychostimulant medication. Aus. NZ J. Psych.37(5), 570–576 (2003).
  • Kempton S, Vance A, Maruff P, Luk E, Costin J, Pantelis C. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psych. Med.29(3), 527–538 (1999).
  • Spencer T, Biederman J, Heiligenstein J et al. An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. J. Child Adolesc. Psychopharmacol.11(3), 251–265 (2001).
  • Alexopoulos GS, Raue P, Arean P. Problem-solving therapy versus supportive therapy in geriatric major depression with executive dysfunction. Am. J. Geriatric Psych.11(1), 46–52 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.